| | This journal provides immediate access to some articles. Emergence of influenza A viruses. R J Webby and R G Webster PMCID: PMC1088557 Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. J K Taubenberger, A H Reid, T A Janczewski, and T G Fanning PMCID: PMC1088558 Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection. M Hatta, G Neumann, and Y Kawaoka PMCID: PMC1088559 The haemagglutinin gene, but not the neuraminidase gene, of 'Spanish flu' was a recombinant. M J Gibbs, J S Armstrong, and A J Gibbs PMCID: PMC1088560 The so-called Great Spanish Influenza Pandemic of 1918 may have originated in France in 1916. J S Oxford PMCID: PMC1088561 The evolution of human influenza viruses. A J Hay, V Gregory, A R Douglas, and Y P Lin PMCID: PMC1088562 The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. G G Brownlee and E Fodor PMCID: PMC1088563 Perspectives on antiviral use during pandemic influenza. F G Hayden PMCID: PMC1088564 Zanamivir: from drug design to the clinic. M Elliott PMCID: PMC1088565 Treatment of influenza with neuraminidase inhibitors: virological implications. N A Roberts PMCID: PMC1088566 Clinical effectiveness and cost effectiveness of zanamivir (Relenza): translating the evidence into clinical practice, a National Institute for Clinical Excellence view. D Barnett PMCID: PMC1088567 RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza. D Young, C Fowler, and K Bush PMCID: PMC1088568 A flu optical immunoassay (ThermoBioStar's FLU OIA): a diagnostic tool for improved influenza management. S P Tucker, C Cox, and J Steaffens PMCID: PMC1088569 Rapid diagnostics: the detection of neuraminidase activity as a technology for high-specificity targets. C D Shimasaki, K E Achyuthan, J A Hansjergen, and J R Appleman PMCID: PMC1088570 Influenza diagnosis and treatment: a view from clinical practice. D M Fleming PMCID: PMC1088571 Zanamivir: an alternative translation. J Collier PMCID: PMC1088572 Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children. R B Belshe and W C Gruber PMCID: PMC1088573 Developing vaccines against pandemic influenza. J M Wood PMCID: PMC1088574 Soluble recombinant influenza vaccines. W Fiers, S Neirynck, T Deroo, X Saelens, and W M Jou PMCID: PMC1088575 Plasmid-only rescue of influenza A virus vaccine candidates. J H Schickli, A Flandorfer, T Nakaya, L Martinez-Sobrido, A García-Sastre, and P Palese PMCID: PMC1088576 Corrections Errata: The population genetics of Trypanosoma brucei and the origin of human infectivity PMCID: PMC1088577 Corrects: A MacLeod, et al. The population genetics of Trypanosoma brucei and the origin of human infectivity. Philos Trans R Soc Lond B Biol Sci. 2001 July 29; 356(1411): 1035–1044. Errata: Memorial to Bill Hamilton PMCID: PMC1088578 Corrects: R M May. Memorial to Bill Hamilton. Philos Trans R Soc Lond B Biol Sci. 2001 June 29; 356(1410): 785–787. |
